Anderson Kirstie N, Pilsworth Samantha, Sharples Linda D, Smith Ian E, Shneerson John M
Respiratory Support and Sleep Centre, Papworth Hospital Papworth Everard, Cambridge, UK.
Sleep. 2007 Oct;30(10):1274-81. doi: 10.1093/sleep/30.10.1274.
To review the clinical and polysomnographic characteristics of idiopathic hypersomnia as well as the long-term response to treatment.
The Respiratory Support and Sleep Centre at Papworth Hospital, Cambridge, UK.
A large database of more than 6000 patients with sleep disorders was reviewed. A retrospective study of the clinical and polysomnographic characteristics of 77 patients with idiopathic hypersomnia was performed. Comparison with a similar group of patients with narcolepsy was performed. The response to drug treatment was assessed in 61 patients over a mean follow-up of 3.8 years.
Idiopathic hypersomnia was 60% as prevalent as narcolepsy. Comparison with a similar group of patients with narcolepsy showed that those with idiopathic hypersomnia were more likely to have prolonged unrefreshing daytime naps, a positive family history, increased slow-wave sleep, and a longer sleep latency on the Multiple Sleep Latency Test. The results of the Multiple Sleep Latency Test were not helpful in predicting disease severity or treatment response. The clinical features were heterogeneous and of variable severity. The majority of patients with idiopathic hypersomnia had symptoms that remained stable over many years, but 11% had spontaneous remission, which was never seen in narcolepsy. Two thirds of patients with idiopathic hypersomnolence had a sustained improvement in daytime somnolence with medication, although a third needed high doses or combinations of drugs.
Idiopathic hypersomnolence has characteristic clinical and polysomnographic features but the prolonged latency on the Multiple Sleep Latency Test raises doubt about the validity of this test within the current diagnostic criteria. The disease often responds well to treatment and a substantial minority of patients appear to spontaneously improve.
回顾特发性嗜睡症的临床和多导睡眠图特征以及长期治疗反应。
英国剑桥帕普沃思医院呼吸支持与睡眠中心。
对一个超过6000例睡眠障碍患者的大型数据库进行了回顾。对77例特发性嗜睡症患者的临床和多导睡眠图特征进行了回顾性研究。与一组类似的发作性睡病患者进行了比较。对61例患者进行了平均3.8年的随访,评估了药物治疗的反应。
特发性嗜睡症的患病率是发作性睡病的60%。与一组类似的发作性睡病患者相比,特发性嗜睡症患者更有可能出现日间小睡时间延长且不能解乏、家族史阳性、慢波睡眠增加以及多次睡眠潜伏期试验的睡眠潜伏期延长。多次睡眠潜伏期试验的结果无助于预测疾病严重程度或治疗反应。临床特征具有异质性且严重程度各异。大多数特发性嗜睡症患者的症状在多年内保持稳定,但11%的患者出现自发缓解,这在发作性睡病中从未见过。三分之二的特发性嗜睡症患者用药后日间嗜睡症状持续改善,尽管三分之一的患者需要高剂量或联合用药。
特发性嗜睡症具有特征性的临床和多导睡眠图特征,但多次睡眠潜伏期试验的延长潜伏期对该试验在当前诊断标准中的有效性提出了质疑。该疾病通常对治疗反应良好,并且相当一部分患者似乎会自发改善。